Net Income (Loss) Attributable to Parent in USD of GOLDENWELL BIOTECH, INC. from Q3 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Goldenwell Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2019 to Q2 2025.
  • Goldenwell Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2025 was -$5.22K, a 89.5% increase year-over-year.
  • Goldenwell Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2025 was -$90.1K, a 34.3% increase year-over-year.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$131K, a 12% decline from 2023.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$117K, a 88.1% increase from 2022.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$985K, a 742% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

GOLDENWELL BIOTECH, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$90.1K -$5.22K +$44.7K +89.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-09-12
Q1 2025 -$135K -$34.4K -$3.32K -10.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-27
Q4 2024 -$131K -$27.5K -$6.66K -32% Oct 1, 2024 Dec 31, 2024 10-K 2025-05-15
Q3 2024 -$125K -$23.1K +$12.3K +34.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-26
Q2 2024 -$137K -$49.9K -$22.8K -84.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-09-12
Q1 2024 -$114K -$31.1K +$2.55K +7.59% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-27
Q4 2023 -$117K -$20.8K +$900K +97.7% Oct 1, 2023 Dec 31, 2023 10-Q 2024-11-26
Q3 2023 -$1.02M -$35.4K -$30.8K -672% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-26
Q2 2023 -$986K -$27.1K -$284 -1.06% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-22
Q1 2023 -$985K -$33.6K -$226 -0.68% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$985K -$920K -$891K -3015% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 -$94.3K -$4.58K +$13.2K +74.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$107K -$26.8K -$3.22K -13.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 -$104K -$33.4K +$12.7K +27.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-19
Q4 2021 -$117K -$29.5K -$26.6K -893% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-02-06
Q3 2021 -$90.4K -$17.8K -$16.9K -1920% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-02-06
Q2 2021 -$73.5K -$23.6K -$23.4K -16626% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-02-06
Q1 2021 -$50.1K -$46.1K -$43.8K -1879% Jan 1, 2021 Mar 31, 2021 10-K/A 2023-02-06
Q4 2020 -$6.32K -$2.98K Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-03
Q3 2020 -$879 +$1.11K +55.8% Jul 1, 2020 Sep 30, 2020 10-Q 2022-01-03
Q2 2020 -$141 Apr 1, 2020 Jun 30, 2020 10-Q 2021-12-02
Q1 2020 -$2.33K Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-05
Q3 2019 -$1.99K Jul 1, 2019 Sep 30, 2019 10-Q 2021-02-23

GOLDENWELL BIOTECH, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$131K -$14.1K -12% Jan 1, 2024 Dec 31, 2024 10-K 2025-05-15
2023 -$117K +$868K +88.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-05-15
2022 -$985K -$868K -742% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 -$117K -$111K -1750% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-13
2020 -$6.32K -$4.01K -174% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-02-06
2019 -$2.31K Jan 1, 2019 Dec 31, 2019 10-K 2021-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.